日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Congenital Hyperinsulinism India Association: An Approach to Address the Challenges and Opportunities of a Rare Disease

印度先天性高胰岛素血症协会:应对罕见病挑战与机遇的途径

Contractor, Jaikumar B; Radha, Venkatesan; Shah, Krati; Singh, Praveen; Tadepalli, Sunil; Nimbalkar, Somashekhar; Mohan, Viswanathan; Shah, Pratik

Larazotide Acetate Protects the Intestinal Mucosal Barrier from Anoxia/Reoxygenation Injury via Various Cellular Mechanisms

拉拉唑肽醋酸盐通过多种细胞机制保护肠黏膜屏障免受缺氧/复氧损伤

Kim, Jain; Madan, Jay P; Laumas, Sandeep; Krishnan, B Radha; Jin, Younggeon

Racial Disparities in Barriers to Care for Patients With Diabetic Retinopathy in a Nationwide Cohort

全国范围内糖尿病视网膜病变患者就医障碍的种族差异

Huang, Bonnie B; Radha Saseendrakumar, Bharanidharan; Delavar, Arash; Baxter, Sally L

Larazotide acetate induces recovery of ischemia-injured porcine jejunum via repair of tight junctions

醋酸拉唑肽通过修复紧密连接诱导缺血损伤猪空肠的恢复

Zachary M Slifer, Liliana Hernandez, Tiffany A Pridgen, Alexandra R Carlson, Kristen M Messenger, Jay Madan, B Radha Krishnan, Sandeep Laumas, Anthony T Blikslager

In vivo assessment of a delayed release formulation of larazotide acetate indicated for celiac disease using a porcine model

利用猪模型对用于治疗乳糜泻的拉拉唑肽醋酸盐缓释制剂进行体内评估

Enomoto, Hiroko; Yeatts, James; Carbajal, Liliana; Krishnan, B Radha; Madan, Jay P; Laumas, Sandeep; Blikslager, Anthony T; Messenger, Kristen M

Pharmacokinetics of the Novel Echinocandin CD101 in Multiple Animal Species

新型棘白菌素CD101在多种动物体内的药代动力学

Ong, Voon; James, Kenneth D; Smith, Steven; Krishnan, B Radha

Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin

新型棘白菌素类药物CD101的稳定性、安全性和有效性的临床前评价

Ong, Voon; Hough, Grayson; Schlosser, Michael; Bartizal, Ken; Balkovec, James M; James, Kenneth D; Krishnan, B Radha